Form 13-F position report

TONIX PHARMACEUTICALS HLDG C

Reported by CIBC Asset Management Inc

TNXP CUSIP 890260839 Manager CIK 0001021926

Reported 17,568 shares, unchanged from the prior quarter.

Reported value 101.3%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q2 2025
Shares 17,568 Quarter-end amount reported
Reported value $632,097 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 314028
2025-06-30 632097
2025-09-30 424443
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for TONIX PHARMACEUTICALS HLDG C held by CIBC Asset Management Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -17,568 (-100.0%) 0 $0 2026-02-10
Q3 2025 Unchanged 17,568 0 (0.0%) < 0.01% $424,443 2025-10-31
Q2 2025 Unchanged 17,568 0 (0.0%) < 0.01% $632,097 2025-08-14
Q1 2025 New 17,568 +17,568 (0.0%) < 0.01% $314,028 2025-05-13

Who else reported the position

54 managers reported TONIX PHARMACEUTICALS HLDG C for Q2 2025.

Managers reporting TONIX PHARMACEUTICALS HLDG C in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 420,448 +350,868 < 0.01% $15,127,718 2 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 175,212 +113,175 < 0.01% $6,305,116 2 qtrs
VANGUARD GROUP INC Added 164,732 +73,236 < 0.01% $5,927,057 2 qtrs
NORTHERN TRUST CORPORATION Added 164,022 +150,954 < 0.01% $5,901,511 2 qtrs
STATE STREET CORPORATION Added 123,257 +103,204 < 0.01% $4,434,787 2 qtrs
Nuveen LLC New 51,892 +51,892 < 0.01% $1,867,074 1 qtr
Susquehanna Portfolio Strategies LLC New 41,454 +41,454 0.03% $1,491,515 1 qtr
UBS Group AG Added 22,463 +2,494 < 0.01% $808,218 2 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC New 21,732 +21,732 < 0.01% $781,917 1 qtr
MORGAN STANLEY Added 18,928 +16,251 < 0.01% $681,028 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 14, 2025
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
17,568
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.